The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SGNTGT-001: A phase 1 study of SEA-TGT, an effector-function enhanced monoclonal antibody (mAb), in advanced malignancies (trial in progress).
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme
 
Rachel E. Sanborn
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Genentech/Roche; Janssen Oncology; Macrogenics
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - AstraZeneca
 
Anna Rachel Minchom
Honoraria - Bayer; Chugai Pharma; Faron Pharmaceuticals; Merck; Novartis Pharmaceuticals UK Ltd.
Consulting or Advisory Role - Janssen Oncology
Research Funding - Seagen
Travel, Accommodations, Expenses - Amgen
 
Diwakar Davar
Honoraria - Array BioPharma; Immunocore; Instil Bio; Merck; Tesaro; Vedanta Biosciences
Consulting or Advisory Role - Instil Bio; Shionogi (I); Vedanta Biosciences
Research Funding - Bristol-Myers Squibb; CellSight Technologies; Checkmate Pharmaceuticals; medpacto; Merck; Tesaro; Zucero Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Application No.: 63/124,231
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi-Sankyo; Foundation Medicine; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Vincent Ribrag
Honoraria - AZD; Gilead Sciences; Incyte; Infinity Pharmaceuticals; NanoString Technologies; Novartis; roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Immune Design; Incyte; Infinity Pharmaceuticals; MSD; NanoString Technologies; PharmaMar; Roche; Roche/Genentech
Research Funding - arGEN-X BVBA; argenx (Inst); Astex Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline/Adaptimmune (Inst)
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - AZD; azd; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche
 
Amitkumar Mehta
Stock and Other Ownership Interests - Witty Health
Consulting or Advisory Role - Aileron Therapeutics; AstraZeneca; Bristol-Myers Squibb; Carevive; Incyte; Kite, a Gilead company; Kyowa Kirin International; Pharmacyclics; Rigel; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - AstraZeneca; Gilead Sciences; Incyte; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals
Research Funding - ADC Therapeutics; ADC Therapeutics (Inst); Affimed Therapeutics; Aileron Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Carevive (Inst); Epizyme (Inst); Forty Seven (Inst); Gilead Sciences (Inst); incyte (Inst); Innate Pharma; Juno Therapeutics (Inst); Merck (Inst); oncotartis (Inst); Pharmacyclics/Janssen (Inst); Rhizen Pharmaceuticals; Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics
 
Francine M. Foss
Consulting or Advisory Role - Acrotech Biopharma; Eisai; Eisai; Mallinckrodt; miRagen; Portola Pharmaceuticals; Seagen; Verastem
Speakers' Bureau - Seagen
Research Funding - Astex Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Miragen (Inst)
 
Jasmine M. Zain
Honoraria - Kiyowa Kirin; Mundipharma; Seagen; verastem
Consulting or Advisory Role - Legend Biotech ; Ono Pharmaceutical; secura bio; verastem
Speakers' Bureau - Celgene; Mallinckrodt; Seagen
Research Funding - Affimed Therapeutics; crispr therapeutics; OncoTartis; Seagen; secura bio
Travel, Accommodations, Expenses - Seagen
 
Andres Forero-Torres
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)